Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R24)

Funding Agency:
National Institutes of Health

This FOA encourages applications from institutions and organizations proposing research aimed at characterizing animal stem cells and improving existing, and creating new, animal models for human disease conditions.  The intent of this initiative is to facilitate the use of stem cell-based therapies for regenerative medicine. The initiative focuses on the following areas: 1) comparative analysis of animal and human stem cells to provide information for selection of the most predictive and informative model systems; 2) development of new technologies for stem cell characterization and transplantation; and 3) improvement of animal disease models for stem cell-based therapeutic applications. 

Companion FOAs:

PAR-16-093, R01, Investigator Initiated Research Project Grants,

PAR-16-094, R21, Exploratory/Developmental Grant


  • R24 Due Dates: Jan. 25, May 25, Sep. 25
  • AIDS Due Dates: Jan. 7, May 7, Sep. 7

PAR-16-322 Expiration Date September 8, 2019




Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

May 25, 2019